452 related articles for article (PubMed ID: 17244029)
1. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
[TBL] [Abstract][Full Text] [Related]
2. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
Zhang X; Egawa K; Xie Y; Ihn H
Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors.
Fukumaru K; Yoshii N; Kanzaki T; Kanekura T
J Dermatol; 2007 Nov; 34(11):746-53. PubMed ID: 17973813
[TBL] [Abstract][Full Text] [Related]
4. Maspin expression in normal skin and usual cutaneous carcinomas.
Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
Virchows Arch; 2002 Dec; 441(6):551-8. PubMed ID: 12461611
[TBL] [Abstract][Full Text] [Related]
5. Expression of the hair stem cell-specific marker nestin in epidermal and follicular tumors.
Kanoh M; Amoh Y; Sato Y; Katsuoka K
Eur J Dermatol; 2008; 18(5):518-23. PubMed ID: 18693153
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratin profile in basal cell carcinoma.
Alessi E; Venegoni L; Fanoni D; Berti E
Am J Dermatopathol; 2008 Jun; 30(3):249-55. PubMed ID: 18496426
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody Ber-EP4 reliably discriminates between microcystic adnexal carcinoma and basal cell carcinoma.
Krahl D; Sellheyer K
J Cutan Pathol; 2007 Oct; 34(10):782-7. PubMed ID: 17880584
[TBL] [Abstract][Full Text] [Related]
8. Immunoexpression of Bcl-x in squamous cell carcinoma and keratoacanthoma: differences in pattern and correlation with pathobiology.
Tan KB; Lee YS
Histopathology; 2009 Sep; 55(3):338-45. PubMed ID: 19723149
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical study of calretinin in normal hair follicles and tumors with follicular differentiation].
González-Guerra E; Requena L; Kutzner H
Actas Dermosifiliogr; 2008; 99(6):456-63. PubMed ID: 18558053
[TBL] [Abstract][Full Text] [Related]
10. p63 expression in normal skin and usual cutaneous carcinomas.
Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
J Cutan Pathol; 2002 Oct; 29(9):517-23. PubMed ID: 12358808
[TBL] [Abstract][Full Text] [Related]
11. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
[TBL] [Abstract][Full Text] [Related]
12. Expression of androgen receptor by fibroepithelioma of Pinkus: evidence supporting classification as a basal cell carcinoma variant?
Katona TM; Ravis SM; Perkins SM; Moores WB; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):7-12. PubMed ID: 17284955
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical galectin-3 expression in non-melanoma skin cancers.
Kapucuoglu N; Basak PY; Bircan S; Sert S; Akkaya VB
Pathol Res Pract; 2009; 205(2):97-103. PubMed ID: 18951731
[TBL] [Abstract][Full Text] [Related]
14. "Squamoid eccrine ductal carcinoma": an unusual low-grade case with follicular differentiation. Are these tumors squamoid variants of microcystic adnexal carcinoma?
Kavand S; Cassarino DS
Am J Dermatopathol; 2009 Dec; 31(8):849-52. PubMed ID: 19786851
[TBL] [Abstract][Full Text] [Related]
15. Does the peritumoral stroma of basal cell carcinoma recapitulate the follicular connective tissue sheath?
Sellheyer K; Krahl D
J Cutan Pathol; 2011 Jul; 38(7):551-9. PubMed ID: 21366662
[TBL] [Abstract][Full Text] [Related]
16. Comparison of oncostatin M expression in keratoacanthoma and squamous cell carcinoma.
Tran TA; Ross JS; Sheehan CE; Carlson JA
Mod Pathol; 2000 Apr; 13(4):427-32. PubMed ID: 10786810
[TBL] [Abstract][Full Text] [Related]
17. Functional thrombomodulin expression on epithelial skin tumours as a differentiation marker for suprabasal keratinocytes.
Mizutani H; Ohyanagi S; Hayashi T; Groves RW; Suzuki K; Shimizu M
Br J Dermatol; 1996 Aug; 135(2):187-93. PubMed ID: 8881658
[TBL] [Abstract][Full Text] [Related]
18. An overview of Bcl-2 expression in histopathological variants of basal cell carcinoma, squamous cell carcinoma, actinic keratosis and seborrheic keratosis.
Puizina-Ivić N; Sapunar D; Marasović D; Mirić L
Coll Antropol; 2008 Oct; 32 Suppl 2():61-5. PubMed ID: 19138009
[TBL] [Abstract][Full Text] [Related]
19. Expression of bcl-2 antagonist bak in inflammatory and neoplastic skin diseases.
Tomková H; Fujimoto W; Arata J
Br J Dermatol; 1997 Nov; 137(5):703-8. PubMed ID: 9415228
[TBL] [Abstract][Full Text] [Related]
20. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
